LogicBio Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

LogicBio Therapeutics, Inc. (Nasdaq:LOGC) announced on June 1, 2021, that CEO Frederic Chereau will participate in virtual fireside chats at two investor conferences. The events include the Jefferies Virtual Healthcare Conference on June 4 at 9:30 AM ET and the JMP Securities Life Sciences Conference on June 16 at 2:00 PM ET. Interested parties can access live webcasts through the Investors section of the company's website. LogicBio focuses on pioneering gene delivery and editing platforms to address rare diseases, utilizing innovative technologies like GeneRide™ and sAAVy™.

LEXINGTON, Mass., June 1, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced that Frederic Chereau, chief executive officer of LogicBio, will participate in virtual fireside chats at the following upcoming investor conferences:

• Jefferies Virtual Healthcare Conference, Friday, June 4, at 9:30 AM ET.
• JMP Securities Life Sciences Conference, Wednesday, June 16, at 2:00 PM ET.

Where applicable, live webcasts of the fireside chats can be accessed through the Investors section of the Company's website at https://investor.logicbio.com.

About LogicBio Therapeutics

LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The Company's proprietary GeneRide™ platform is a new approach to precise gene insertion that has the potential to harness a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The Company is based in Lexington, MA. For more information, visit https://www.logicbio.com/, which does not form a part of this release.

Media Contacts:
Adam Daley
Berry & Company Public Relations
W: 212-253-8881
C: 614-580-2048
adaley@berrypr.com

Jenna Urban
Berry & Company Public Relations
W: 212-253-8881
C: 203-218-9180
jurban@berrypr.com 

Investor Contacts:
Matt Lane
Gilmartin Group
(617) 901-7698
matt@gilmartinir.com

View original content:http://www.prnewswire.com/news-releases/logicbio-therapeutics-to-participate-in-upcoming-investor-conferences-301303288.html

SOURCE LogicBio Therapeutics, Inc.

FAQ

When is LogicBio Therapeutics participating in the Jefferies Virtual Healthcare Conference?

LogicBio Therapeutics will participate in the Jefferies Virtual Healthcare Conference on June 4, 2021, at 9:30 AM ET.

What is the date and time for the JMP Securities Life Sciences Conference for LOGC?

The JMP Securities Life Sciences Conference will take place on June 16, 2021, at 2:00 PM ET.

How can I access the live webcasts for LogicBio's investor conferences?

Live webcasts can be accessed through the Investors section of LogicBio's website.

What technologies does LogicBio Therapeutics utilize for gene therapy?

LogicBio Therapeutics utilizes GeneRide™ and sAAVy™ platforms for gene delivery and editing to address rare and serious diseases.